Edesa Biotech Inc.
Organization details
- Legal name
- Edesa Biotech Inc.
- Former names
- Stellar Biotechnologies, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- British Columbia, Canada
- Headquarters city
- Markham
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- EDSA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001540159
Board of directors
-
Carlo Sistilli · DirectorSince 2023
-
Charles Olson V · DirectorSince 2023
-
Da David Liu · DirectorSince 2025
-
Frank R. Oakes · DirectorSince 2023
-
Joan Chypyha · DirectorSince 2023
-
Pardeep Nijhawan · Director · Chief Executive OfficerSince 2023
-
Patrick Marshall · DirectorSince 2023
-
Sean Arthur MacDonald · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.1%
-
97.1%
-
97.1%
-
98.2%
-
98.2%
-
98.2%
-
98.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $233,022
- 9 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Pardeep Nijhawan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +18,677 | — | — |
| Oct 28, 2026 | Pardeep Nijhawan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +27,602 | — | — |
| Oct 5, 2026 | Pardeep Nijhawan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +6,893 | — | — |
| Sep 1, 2026 | Pardeep Nijhawan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +5,714 | — | — |
| Aug 3, 2026 | Pardeep Nijhawan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +5,324 | — | — |
| Jul 2, 2026 | Pardeep Nijhawan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +3,378 | — | — |
| Jun 16, 2026 | Pardeep Nijhawan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +153,550 | $5.21 | $799,996 |
| Jun 1, 2026 | Pardeep Nijhawan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +1,671 | — | — |
| May 27, 2026 | Patrick Marshall Director | Grant or award | +19,000 | — | — |
| May 27, 2026 | Sean Arthur MacDonald Director | Grant or award | +19,000 | — | — |
| May 27, 2026 | Joan Chypyha Director | Grant or award | +19,000 | — | — |
| May 27, 2026 | Weiler Peter J. Officer (Chief Financial Officer) | Grant or award | +64,609 | — | — |
| May 27, 2026 | Brooks Michael J Officer (President) | Grant or award | +64,609 | — | — |
| May 27, 2026 | Carlo Sistilli Director | Grant or award | +19,000 | — | — |
| May 27, 2026 | Charles Olson V Director | Grant or award | +19,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Edesa Biotech Inc.
Who is the CEO of Edesa Biotech Inc.?
Pardeep Nijhawan is Edesa Biotech Inc.'s Chief Executive Officer.
How many directors are on Edesa Biotech Inc.'s board?
Edesa Biotech Inc.'s board has 8 directors: Carlo Sistilli, Charles Olson V, Da David Liu, Frank R. Oakes, Joan Chypyha, Pardeep Nijhawan, Patrick Marshall and Sean Arthur MacDonald.
Are Edesa Biotech Inc. insiders buying or selling shares?
Over the last 12 months, Edesa Biotech Inc. insiders bought $233,022 of shares in 9 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="edesa-biotech-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.